<DOC>
<DOCNO>
EP-0008255
</DOCNO>
<TEXT>
<DATE>
19800220
</DATE>
<IPC-CLASSIFICATIONS>
A61K-39/255 A61K-39/245 <main>C12N-7/00</main> 
</IPC-CLASSIFICATIONS>
<TITLE>
herpes virus vaccine and its preparation.
</TITLE>
<APPLICANT>
merck & co incus<sep>merck & co. inc.<sep>merck &amp; co., inc.126, east lincoln avenue p.o. box 2000rahway new jersey 07065-0900us<sep>merck & co. inc.<sep>
</APPLICANT>
<INVENTOR>
markus henry zvi<sep>mcaleer william joseph<sep>markus, henry zvi<sep>mcaleer, william joseph<sep>markus, henry zvi1517 thornberry roadwyncote, pennsylvania 19095us<sep>mcaleer, william joseph717 marietta driveambler, pennsylvania 19002us<sep>markus, henry zvi<sep>mcaleer, william joseph  <sep>markus, henry zvi 1517 thornberry roadwyncote, pennsylvania 19095us<sep>mcaleer, william joseph717 marietta driveambler, pennsylvania 19002us<sep>
</INVENTOR>
<ABSTRACT>
a new method of formulating herpes class virus vacÂ­ cines, especially marek's disease vaccine.  the virus is  lyophilized in the presence of a ph controlled buffered  stabilizer, so that the vaccine can be reconstituted simply  with distilled water 
</ABSTRACT>
</TEXT>
</DOC>
